ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ARDX Ardelyx Inc

5.13
0.11 (2.19%)
After Hours
Last Updated: 15:51:27
Delayed by 15 minutes

Period:

Draw Mode:

Volume 5,181,805
Bid Price 5.12
Ask Price 5.14
News (1)
Day High 5.175

Low
1.70

52 Week Range

High
5.175

Day Low 4.96
Share Name Share Symbol Market Stock Type
Ardelyx Inc ARDX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.11 2.19% 5.13 15:51:27
Open Price Low Price High Price Close Price Previous Close
5.02 4.96 5.175 5.14 5.02
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
20,343 5,181,805 US$ 5.06 US$ 26,243,506 - 1.70 - 5.175
Last Trade Type Quantity Price Currency
15:51:27 formt 270 US$ 5.13 USD

Ardelyx (ARDX) Options Flow Summary

Overall Flow

Bearish

Net Premium

-517k

Calls / Puts

133.33%

Buys / Sells

40.00%

OTM / ITM

16.67%

Sweeps Ratio

0.00%

Ardelyx Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.19B 232.14M - 52.16M -67.21M -0.29 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Ardelyx News

Date Time Source News Article
12/06/202315:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/05/202315:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/01/202315:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/30/202315:28Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
11/22/202316:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/21/202315:02GlobeNewswire Inc.Ardelyx, Inc. Reports Employment Inducement Grants
11/21/202307:01GlobeNewswire Inc.Ardelyx to Participate at the Piper Sandler 35th Annual..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ARDX Message Board. Create One! See More Posts on ARDX Message Board See More Message Board Posts

Historical ARDX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.115.1754.114.714,916,8221.0224.82%
1 Month4.045.1753.434.244,153,5671.0926.98%
3 Months4.865.1753.163.966,455,2610.275.56%
6 Months3.655.1753.163.935,711,9601.4840.55%
1 Year1.895.1751.703.696,555,2773.24171.43%
3 Years6.409.230.49022.546,193,003-1.27-19.84%
5 Years2.5010.43430.49022.743,940,7942.63105.2%

Ardelyx Description

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com